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Essentials
• Tissue factor (TF) represents a central link between
hemostasis and inflammation.
• We studied the roles of myeloid and airway epithelial
TF in acid-caused acute lung injury (ALI).
• TF on myeloid cells displays a non-coagulatory role
regulating the inflammatory response in ALI.
• Airway epithelial TF contributes to hemostatic func-
tions, but is dispensable in ALI pathogenesis.
Summary. Introduction: Acute lung injury (ALI) is a life-
threatening condition characterized by damaged alveolar–
capillary structures and activation of inflammatory and
hemostatic processes. Tissue factor (TF) represents a cru-
cial link between inflammation and coagulation, as
inflammatory mediators induce myeloid TF expression,
and TF initiates extrinsic coagulation. Objective: As pul-
monary inflammation stimulates TF expression and TF
modulates immune responses, we aimed to elucidate its
impact on ALI. In particular, we wanted to distinguish
the contributions of TF expressed on airway epithelial
cells and TF expressed on myeloid cells. Methods: Mice
with different cell type-specific TF deficiency and wild-
type littermates were intratracheally treated with
hydrochloric acid, and leukocyte recruitment, cytokine
levels, thrombin–antithrombin (TAT) complexes and pul-
monary protein-rich infiltrates were analyzed. Results:
Our data demonstrate that a lack of epithelial TF did not
influence acute responses, as bronchoalveolar neutrophil
accumulation 8 h after ALI induction was unaltered.
However, it led to mild, prolonged inflammation, as pul-
monary leukocyte and erythrocyte numbers were still
increased after 24 h, whereas those in wild-type mice had
returned to basal levels. In contrast, myeloid TF was pri-
marily involved in regulating the acute phase of ALI
without affecting local coagulation, as indicated by
increased bronchoalveolar neutrophil infiltration, pul-
monary interleukin-6 levels, and edema formation, but
equal TAT complex formation, 8 h after ALI induction.
This augmented inflammatory response associated with
myeloid TF deficiency was confirmed in vitro, as
lipopolysaccharide-stimulated TF-deficient alveolar
macrophages released increased levels of chemokine
(C-X-C motif) ligand 1 and tumor necrosis factor-a as
compared with wild-type macrophages. Conclusion: We
conclude that myeloid TF dampens inflammation in acid-
induced ALI.
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Introduction
Tissue factor (TF), also referred to as factor III, thrombo-
plastin, or CD142, is a glycosylated integral transmem-
brane protein that initiates the extrinsic coagulation
cascade. TF is constitutively expressed on the surface by
various extravascular tissues, such as pulmonary epithe-
lium. Upon injury, e.g. to the alveolar–endothelial barrier,
extravascular TF is exposed to plasmatic coagulation fac-
tors, e.g. FVII, and initiates clot formation. The generated
thrombin triggers fibrin formation, which stabilizes the
primary platelet plug. Hence, TF is important for protect-
ing vascular integrity, and thus preventing uncontrolled
and life-threatening blood loss [1–3]. Upon infection or
inflammation, TF expression is readily induced on leuko-
cytes that are usually devoid of surface TF. These TF-
expressing leukocytes comprise members of the first line of
defense, such as macrophages, but also circulating mono-
cytes or neutrophils. Furthermore, blood vessel-lining
endothelial cells are able to synthesize TF [4–6]. Stimuli
triggering bloodborne TF expression during infection
include pathogen-associated molecular patterns, e.g.
lipopolysaccharide (LPS) or lipoteichoic acid, and endoge-
nous inflammatory cytokines, e.g. tumor necrosis factor
(TNF)-a and interleukin (IL)-1b [7,8]. This process
involves several transcription factors that are essential for
immune functions, such as nuclear factor-jB (NF-jB),
AP-1, nuclear factor of activated T cells, and early growth
response-1 [9–12]. Hence, the properties of TF are not
strictly confined to hemostatic functions, but also promote
host defense and inflammation [13]. Therefore, reduced
TF activity in mice leads to more severe bacteremia and
increased mortality [14]. However, uncontrolled coagula-
tion cascade activation markedly contributes to dissemi-
nated intravascular coagulation. Correspondingly, reduced
TF expression protects mice from systemic endotoxemia
[15], indicating that finely balanced TF expression is essen-
tial for adequate immune responses during sepsis. Further-
more, TF inhibition prevents secondary lung injury in a
baboon sepsis model [16]. However, it remains incom-
pletely understood how TF contributes to local infection
and inflammation in organs such as the lung.
Acute lung injury (ALI) represents a multifactorial dis-
ease that can be induced by aspiration of non-infectious
acidic gastric contents as well as by pathogenic lung infec-
tions. The role of TFs in different pathologies of lung
injury are still undefined. A recent study investigating
low-TF mice subjected to LPS-induced ALI suggested
that reduced TF expression exacerbates disease pathogen-
esis [17]. Cell type-specific TF deficiency in type I and
type II lung epithelial cells worsens LPS-induced ALI by
increasing alveolar permeability and hemorrhage. In con-
trast, mice devoid of myeloid TF show no overt differ-
ences in the severity of lung damage [18]. In the present
study, we focused on cell type-specific roles of TF in acid-
induced ALI. This clinically relevant mouse model mimics
aspiration of gastric contents leading to lung complica-
tions (particularly in patients admitted to intensive care
units), which accounts for 11% of all ALI cases in clinics
[19], and is characterized by the release of endogenous
alarm signals, damage-associated molecular patterns
(DAMPs), and simultaneous Toll-like receptor activation
[20,21]. The resulting inflammation is associated with
endothelial cell activation, leukocyte and platelet influx,
activation of coagulation, fibrin deposition, and, eventu-
ally, damage to the alveolar–capillary barrier [22]. Nota-
bly, activation of the coagulation cascade plays a relevant
role in disease progression [23].
As coagulatory and inflammatory processes affect the
pathogenesis of ALI, we wanted to elucidate the impact
of TF on these events during ALI. Thus, we endeavored
to elucidate whether the presence of TF is required to
protect the integrity of alveolar–capillary structures.
Moreover, we aimed to define cell type-specific functions
of TF, and therefore performed acid-induced ALI in mice
with TF deficiency in either myeloid cells (monocytes,
macrophages, and granulocytes) or alveolar type I and
type II epithelial cells. Our data indicate that TF acts in a
cell type-specific manner, and that myeloid TF, in con-
trast to airway epithelial TF, dampens inflammatory
responses during acid-induced ALI.
Materials and methods
Mice
All experiments and animal studies were conducted
according to institutional guidelines and were approved
by the Animal Care and Use Committee of the Medical
University of Vienna (BMWF-66.009/0320-II/3b/2013;
BMWF-66.009/0254-ll/3b/2013).
All animal experimentation was littermate-controlled.
We used previously described LysM cre+/TFflox/flox
(referred to as TFΔmye) [24,25] or SPC cre+/TFflox/flox
(referred to as TFΔepi) [18] mice on a C57BL/6J
genetic background (backcrossed for six generations), and
8–12-week-old, sex-matched littermates (control
LysM cre/TFflox/flox and SpcCre/TFflox/flox, referred
as TF+/+ or wild-type).
Direct PCR of lysed tissue was performed for genotyp-
ing. (Primers: TF forward, 50-ATGAGGAGCTGTGTTA
AAGGGTCGCAGA-30; TF reverse, 50-TGCAGTAA
ATGCACGTGTCTGCCAT-30; Cre forward, 50-TCGC
GATTATCTTCTATATCTTCAG-30; Cre reverse, 50-GC
TCGACCAGTTTAGTTACCC-30.)
Anesthesia
Mice were anesthetized with Ketaminol (50 mg kg1) (Inter-
vet International, Unterschleißheim, Germany) and Xylasol
(5 mg kg1) (Dr E. Gr€aub, Bern, Switzerland) or Forane
(isoflurane; Abbott Laboratories, Queenborough, UK).
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ALI and administration of anti-TF antibody
Sedated mice were intratracheally treated with 50 lL of
0.1 M hydrochloric acid (HCl) to induce ALI.
Wild-type mice (C57BL/6J genetic background) were
intraperitoneally injected once with monoclonal inhibitory
rat anti-mouse TF (1H1) (20 lg g1) prior to ALI induc-
tion.
Bronchoalveolar lavage fluid (BALF) and alveolar
macrophage isolation and stimulation
For quantification of cytokines and leukocytes in the bron-
choalveolar space, the trachea was exposed and punctured
with a vein catheter, and the bronchoalveolar space was
lavaged with 1 mL of phosphate-buffered saline (PBS).
Cells were pelleted for flow cytometry (600 9 g, 10 min),
and supernatants were used for ELISA.
Alveolar macrophages were isolated by repeating lavaging
(10 times), and seeded into non-tissue culture-treated plates
(2 h, 37 °C, and 5% CO2; RPMI medium (Sigma-Aldrich,
Vienna, Austria) dosed with 10% fetal bovine serum, 1%
penicillin, streptomycin, and fungizone, and 1% L-glutamine)
before non-adherent lymphocytes were discarded.
Alveolar macrophages were stimulated with 10 ng mL1
or 100 ng mL1 LPS (LPS-EB ultrapure from Escherichia
coli O111:B4; Invivogen, Toulouse, France) for the indi-
cated times, and supernatant or cells with peqGOLD Tri-
Fast (VWR, Darmstadt, Germany) were harvested.
Bone marrow-derived macrophage (BMDM) isolation
Murine bone marrow was isolated and incubated with
granulocyte–macrophage colony-stimulating factor (GM-
CSF) (10 ng mL1) for 1 week to generate BMDMs,
which were then stimulated with LPS (10 ng mL1) for
the indicated times.
Lung homogenization for ELISA and western blotting
Lungs were homogenized in 4 lL of PBS mg–1 with 5-
mm beads in a Precellys24 homogenizer (Bertin Technolo-
gies, Aix-en-Provence, France). Supernatants were mixed
with Greenberger Lysis buffer and protease inhibitor
(Roche Life Sciences, Basel, Switzerland), incubated
(20 min on ice), and centrifuged (135 9 g, 15 min, 4 C),
and the supernatant was used for ELISA.
For immunoblotting, lungs were homogenized in 10 lL
of RIPA buffer mg–1, and supernatants were mixed with
Laemmli buffer.
RNA isolation and quantitative PCR (qPCR)
RNA was isolated from TriFast-homogenized lungs or
macrophages, transcribed into cDNA (High-Capacity
cDNA Reverse transcription Kit; Applied Biosystems,
Carlsbad, CA, USA), and analyzed by qPCR with Fast
SYBR Green Master Mix (Applied Biosystems, Carlsbad,
CA, USA) on a StepOne Real-Time PCR System (Applied
Biosystems, Foster City, CA, USA). The results were eval-
uated according to Pfaffl [26] and expressed as fold con-
trol values. Primer sequences are supplied in Data S1.
Western blotting
Proteins were separated by SDS-PAGE (10% acrylamide
gels), and semi-dry-blotted onto a poly(vinylidene difluo-
ride) membrane. The fibrin b-monomer 59D8 and anti-b-
actin (Sigma-Aldrich) and horseradish peroxidase-linked
secondary antibodies were used. Immunoblots were devel-
oped with SuperSignal West Femto Maximum Sensitivity
Substrate (Thermo Fisher Scientific, Waltham, MA,
USA), imaged with FluorChem HD2 Chemiluminesence
Imager (Alpha Innotech, San Leandro, CA, USA), and
densitometrically analyzed with IMAGEJ 1.47v. Bands were
normalized to b-actin.
Flow cytometry
BALF cells were incubated (20 min) with anti-CD45–
PerCP, anti-F4/80–fluorescein isothiocyanate, anti-Ly6G/
Ly6C–phycoerythrin, and anti-Ter119–allophycocyanin
(1 : 80; BioLegend, London, UK), fixed with 1%
formaldehyde, and measured by flow cytometry (BD
Accuri flow cytometer with BD ACCURIC6, and FLOWJO 9
[Treestar, Ashland, OR, USA]). The following gating strat-
egy was applied. CD45+ cells (leukocytes) were analyzed
for F4/80 positivity (macrophages). Ly6C+ macrophages
were termed inflammatory macrophages. CD45+ F4/80
cells were analyzed for Ly6G expression (neutrophils).
Total cell counts of BALF were calculated by multiply-
ing the events by
Final dilution for flowcytometer
Measured volume
Resupensionvolume
Stained volume
 
 Injected PBS
Recollected PBS
Histologic analysis
The left lung was extracted, fixed in 4% formaldehyde,
and embedded in paraffin. Three-micrometer lung sec-
tions were stained with anti-mouse GR-1 or TF antibody,
and counterstained with hematoxylin or with hematoxylin
and eosin (Carl Roth, Karlsruhe, Germany). Images were
obtained with an Axio Imager.Z1 microscope (Carl Zeiss,
Vienna, Austria).
TF activity assay
TF activity was determined as previously described [27].
Briefly, BALF was diluted 1 : 6 with Hanks’ balanced
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salt solution with 0.1% bovine serum albumin (HBSA),
and microvesicles were pelleted (18 000 9 g, 20 min,
4 °C), washed, and incubated with anti-mouse TF (1H1)
(100 lg mL1) or control IgG (15 min) before addition
of FVII (4.88 nM), FX (150 nM), and CaCl2 (10 mM). The
reaction was stopped by addition of EDTA HBSA buffer
before addition of chromogenic substrate and absorbance
measurement. TF-dependent activated FX (FXa) genera-
tion was determined by subtracting FXa levels generated
in the presence of TF antibody from the levels in IgG
control samples.
ELISA
ELISAs were performed according to manufacturer’s pro-
tocols. Myeloperoxidase (MPO), IL-33 and IL-6, and che-
mokine (C-X-C-motif) ligand-1 (KC), TNF-a and
thrombin–antithrombin (TAT) ELISAs were purchased
from eBioscience (San Diego, USA), R&D Systems (Min-
neapolis, MN, USA) and Siemens Healthcare Diagnostics
(Vienna, Austria), respectively. Absorbance was measured
at 450 nm with an EL808 Ultra Microplate Reader (Bio-
Tek Instruments, Winooski, VT, USA).
Bicinchoninic acid (BCA) assay
The protein concentration in BALF was determined with a
Pierce BCAProteinAssayKit (ThermoFisher Scientific,Wal-
tham,MA,USA) according to themanufacturer’s guidelines.
Edema formation
Murine lungs were extracted, weighed, dried at 55 °C for
48 h, and weighed again. The ratio between wet weight
and dry weight was calculated.
Statistical analysis
Data were depicted as bar diagrams showing the
mean  standard error of the mean, as box plots indicat-
ing the median, the first and third quartiles, and the mini-
mum and maximum, or as scatter plots with indicated
means. The results were evaluated with GRAPHPAD PRISM 5
(GraphPad, San Diego, CA, USA) by one-way-ANOVA with
Dunn’s multiple comparisons test, two-way ANOVA with
Sidak’s multiple comparisons test, unpaired, two-tailed
t-tests, or the Mann–Whitney test, if the samples did not
pass the Kolmogorov–Smirnov test for normal distribu-
tion. A P-value of < 0.05 was considered to be significant.
Results
TF expression during acid-induced ALI
Activation of coagulation is an integral step in the pathol-
ogy of ALI. We established a mouse model of
acid-induced ALI by intratracheal administration of HCl.
Lung TF mRNA expression was increased within the first
8 h of ALI, which represents the most critical time in the
pathology (Fig. 1A), whereas we could not detect simulta-
neous accumulation of fibrin b-monomers in lungs
(Fig. 1B–D). This indicates rather modest activation of
coagulation during acid-induced ALI. To investigate the
role of TF in acid-induced ALI, we used mice with a cell
type-specific TF deficiency (Fig. S1) either in myeloid cells
(TFDmye) or in lung epithelial cells (TFDepi) in littermate-
controlled experiments. We found a significant increase in
TF mRNA expression in TFDmye mice during ALI, which
was significantly more pronounced than in wild-type mice
(Fig. 1E). This indicates that non-myeloid cells upregulate
TF during ALI. As fibrin generation was only moderately
affected during ALI, we used thrombin, the protease-
cleaving fibrinogen, as a functional readout for coagula-
tion activation. Formed thrombin becomes rapidly inacti-
vated via binding of antithrombin III, leading to the
formation of TAT complexes. However, we found only
modest TAT complex upregulation in BALF 8 h after
ALI, perhaps because of low FVII and FX BALF levels.
TAT complex formation only tends to be increased in
TFDmye mice (Fig. 1F). In vitro, we confirmed TF deletion
at the mRNA level in alveolar macrophages with and
without LPS stimulation (Fig. 1G).
TF on myeloid cells negatively regulates leukocyte
recruitment during acid-induced ALI
One of the most prominent features of ALI is leukocyte
influx, in particular of neutrophils, into the bronchoalveo-
lar compartment. As we observed only a minor impact of
TF induction on coagulation, we investigated whether
upregulated TF could influence inflammation during ALI.
Acid-induced ALI led to significantly enhanced leukocyte
extravasation in TFDmye mice as compared with wild-
type littermates after 8 h, as evidenced by increased
CD45+ leukocyte numbers (Fig. 2A). We further identified
CD45+ F4/80 Ly6G+ cells, representing neutrophils, as
strongly contributing to increased cellular influx. Signifi-
cantly more neutrophils migrated into the bronchoalveolar
compartment in TFDmye mice 8 h after acid-induced ALI
(Fig. 2B). To verify that the majority of neutrophils trans-
migrated through the interstitial barrier, we stained lung
sections for the neutrophil marker GR-1 (brown staining,
arrows), which recognizes both neutrophils and, to a lesser
extent, activated macrophages. We observed that most of
the neutrophils were present within the alveoli, and that
only a subfraction were present in interstitial layers
(Fig. 2C). Furthermore, leukocyte accumulation and lung
damage in TFDmye mice were slightly increased as com-
pared with wild-type mice (Fig 2D). In contrast, flow cyto-
metric analysis of macrophage subsets characterized by
either F4/80+ (Fig. 2E; Fig. S2A) or F4/80+ CD11c+
(Fig. S2B) revealed no difference between TFDmye mice
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and wild-type littermates. Only inflammatory macrophages
(Fig. 2F), characterized by F4/80+ and Ly6C+ [28,29],
were marginally, but not significantly (P = 0.09), increased
in number. To analyze the specificity of this phenomenon,
we applied a leukocyte recruitment model to TFDmye and
wild-type mice. To this end, we induced thioglycollate-eli-
cited sterile inflammation, and analyzed leukocyte influx in
an early phase (4 h) and a late phase (72 h). However, no
differences in infiltrating leukocytes, macrophages or neu-
trophils were observed, perhaps because of the strong
inflammatory stimulus (Fig. S3A–D). In vitro analysis of
alveolar macrophages revealed that, in response to LPS,
TF deficiency increased the release of the chemokine KC,
which primarily attracts neutrophils (Fig. 2G). These data
may indicate that myeloid TF plays a lung-specific role in
regulating leukocyte alveolar trafficking.
TF dampens the inflammatory response in acid-induced ALI
Another hallmark of acid-induced ALI is the induction of
an inflammatory response, which is usually triggered by
endogenous alarmins or DAMPs, owing to cellular dam-
age. DAMPs include nuclear components such as histones
or high-mobility group box 1, but also IL-33 [30]. We
observed a strong increase in the release of IL-33 into the
bronchoalveolar compartment in response to ALI, but no
differences between TFDmye and wild-type littermate mice
(Fig. 3A). Although granulocyte numbers in TFDmye mice
(Fig. 2B) were markedly increased, we found only a slight
trend for increased MPO levels in BALF and lung homo-
genates in TFDmye mice (Fig. 3B). However, analysis of
total protein in BALF revealed an increased protein con-
tent in TFDmye mice subjected to acid-induced ALI as
compared with wild-type mice (Fig. 3C). This finding
points towards increased vascular leakage and loss of
alveolar–capillary barrier function in the lungs of TFDmye
mice. Next, we measured the level of pulmonary IL-6 of
acid-treated mice, which we considered to be the most
robust marker for inflammation in this rather mild
inflammatory model. We observed significantly increased
IL-6 production and release in BALF and total lung after
acid-induced ALI in TFDmye mice as compared with
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Fig. 1. Tissue factor (TF) expression and activation of coagulation during acute lung injury (ALI). (A) TF mRNA expression in lungs of wild-
type mice after HCl-induced ALI was determined by qPCR at the indicated time points. Data show fold control (0 h) values normalized to
hypoxanthine guanine phosphoribosyl transferase (HPRT); numbers are shown in parentheses. (B) Western blot analysis for fibrin-b of homoge-
nized lung samples 8 h after HCl treatment (n = 3) and of controls (n = 2); actin was used as a loading control. (C, D) Western blot densitomet-
ric analysis of (C) fibrinogen and (D) the major fibrin(ogen) degradation product. (E) TF mRNA expression in total lung tissue of control (nTF+/
+ = 2; nTFDmye = 1) and HCl-treated (nTF+/+ = 9; nTFDmye = 4) myeloid TF-deficient (TF
Dmye) or wild-type (TF+/+) mice was analyzed by
q-PCR 8 h after treatment. (F) Thrombin–antithrombin (TAT) complexes in the bronchoalveolar lavage fluid (BALF) of control (n = 4) and
HCl-treated (nTF+/+ = 10; nTFDmye = 12) wild-type or myeloid TF-deficient mice 8 h after treatment. (G) TF mRNA expression of alveolar
macrophages, isolated from lungs of myeloid TF knockout mice and wild-type littermates and stimulated with lipopolysaccharide (LPS)
(100 ng mL1) in vitro for 3 h; n = 5. For statistical analysis, one-way-ANOVA with Dunn’s multiple comparisons test (A), unpaired Student’s
t-tests (E, F) or the Mann–Whitney test (G) were performed; *P < 0.05. Littermate-controlled experiments were performed. a.u., arbitrary units.
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wild-type mice (Fig. 3D,E). However, pulmonary IL-1b
and IL-12 p40 levels were unaltered (Fig. S4A,B).
TF dampens the inflammatory response of macrophages
in vitro
To determine the possible source of increased IL-6 levels
in HCl-treated TFDmye mice and the impact of myeloid
TF on inflammatory responses of macrophages, we iso-
lated alveolar macrophages from naive TFDmye mice and
wild-type littermates. Analysis of IL-6 at the mRNA and
protein levels revealed a significant increase in IL-6
mRNA 3 h after LPS stimulation (Fig. 4A,B). Moreover,
TNF-a mRNA and protein levels were significantly
increased 3 h after LPS treatment (Fig. 4C,D). As alveo-
lar macrophages are very limited in number, and their
development depends on GM-CSF [31], we also used
GM-CSF-induced BMDMs. LPS-stimulated TF-deficient
BMDMs expressed similar levels of IL-6 mRNA and pro-
tein (Fig. 4E,F); however, TNF-a secretion was
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Fig. 2. The effect of myeloid tissue factor (TF) on pulmonary leukocyte recruitment during acute lung injury (ALI). (A, B, E, F) Flow cyto-
metric analysis of leukocytes in the bronchoalveolar lavage fluid of control mice (nTF+/+ = 10; nTFDmye = 11) and HCl-treated (nTF+/+ = 22;
nTFDmye = 27) myeloid TF-deficient mice or wild-type mice 8 h after ALI. (A) CD45
+ leukocytes. (B) CD45+ Ly6G+ F4/80 neutrophils. (E)
CD45+ F4/80+ macrophages. (F) CD45+ Ly6C+ F4/80+ inflammatory macrophages (ncontrol TF+/+ = 9; ncontrol TFDmye = 11;
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performed. PBS, phosphate-buffered saline. [Color figure can be viewed at wileyonlinelibrary.com]
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significantly increased (Fig. 4G). To identify potential sig-
naling pathways affected by TF, we analyzed the expres-
sion of EGR1, IjBa, and STAT1. We found that TF
significantly reduced the expression of EGR1 1 h after
LPS stimulation, whereas IjBa and STAT1 were similarly
expressed (Fig. 4H–J), indicating that the mitogen-acti-
vated kinase pathway was primarily affected, rather than
the interferon and NF-jB pathways.
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As TF activity leads to activated FVII (FVIIa) and
thrombin generation, we examined the effects of 3 h of
human FVIIa and thrombin stimulation on wild-type
BMDMs. We found that concomitant stimulation with
LPS and thrombin significantly reduced the expression of
IL-6 and tended to decrease the expression of TNF-a and
IjBa (Fig. S5A–C). Similarly, FVIIa showed a tendency
to reduce IL-6 levels and, to a lesser extent, TNF-a and
IjBa mRNA levels (Fig. S5D–F). However, in vivo, other
mechanisms, such as the intrinsic coagulation cascade,
can also contribute to thrombin generation. Moreover,
TF can directly signal and thereby modulate macrophage
functions.
These results indicate that the differential expression of
proinflammatory cytokines during ALI is probably depen-
dent on TF surface expression on innate immune cells.
TF on epithelial cells does not contribute to tissue
inflammation 8 h after acid-induced ALI
To determine the contribution of lung epithelial TF to the
pathophysiology of acid-induced ALI, we used TFDepi
mice. We used immunostaining to confirm that there was
appropriate TF deficiency in the lungs of TFDepi mice [18]
(Fig. S1B). Analysis of TF mRNA expression in whole
lung tissue during ALI revealed a trend for increased TF
expression 8 h after acid instillation in wild-type mice. In
contrast, TF mRNA levels were strongly reduced in
TFDepi mice (Fig. 5A), indicating that epithelial cells
express the majority of lung TF mRNA during ALI. The
SPC cre efficiently targets TF expression in most of the
lung epithelial cells [32]. Moreover, upon LPS-induced
ALI, lung epithelial cells represent the major TF-expres-
sing cell type responsible for protection of alveolar–capil-
lary integrity [18]. Hence, we wanted to determine whether
this is also the case during acid-induced ALI. Measure-
ment of TF activity revealed slightly increased FXa gener-
ation and TAT complex formation 8 h after disease
induction in wild-type littermates. In comparison, TFDepi
mice showed a trend for reduced FXa generation but no
differences in TAT complex formation (Fig. 5B,C). Next,
we tested endothelial and epithelial barrier function by
measuring BALF protein levels. Surprisingly, we did not
observe significant differences in BALF protein levels and
edema formation between acid-treated TFDepi mice and
wild-type mice (Fig. 5D,E). Similarly, we did not observe
alterations in erythrocyte levels in BALF (Fig. 5J). To test
the inflammatory response, we measured pulmonary IL-6
mRNA expression and IL-6 protein levels in BALF and
lung tissue, and pulmonary neutrophil transmigration, but
did not detect any differences between acid-treated TFDepi
mice and wild-type littermates (Fig. 5F–I).
Restoration of tissue integrity is disturbed at late stages of
acid-induced ALI in TFDepi mice but not in TFDmye mice
The current literature on TF in ALI pathogenesis is
focused on early responses in disease progression. There-
fore, we aimed to elucidate the effects of TF deletion at late
stages of ALI. Twenty-four hours after acid treatment, the
initial injury and inflammation in wild-type mice had
resolved. Extravasation of leukocytes, including neu-
trophils and macrophages, as well as erythrocytes and pro-
tein infiltrates, returned to baseline levels (Fig. 6A–H).
Surprisingly, we observed increased leukocyte counts in the
bronchoalveolar compartment in TFDepi mice as compared
with wild-type littermates at this time point, suggesting
that TFDepi mice were unable to completely resolve the
mild acid-induced injury (Fig. 6A). Notably, most of this
increase could be attributed to macrophages, and not to
neutrophils (Fig. 6B,C). In contrast, TFDmye mice did not
show any overt pulmonary inflammation 24 h after ALI
induction, as indicated by baseline levels of leukocytes,
macrophages and neutrophils in BALF (Fig. 6D–F). Simi-
larly, we found significantly more erythrocytes in HCl-trea-
ted TFDepi mice and a trend for more protein in the BALF
(Fig. 6G), whereas TFDmye mice and wild-type mice did
not show increased levels in comparison with untreated
mice (Fig. 6H). Edema formation was still slightly
increased in all four HCl-treated groups, but no differences
between genotypes were observed (Fig. 6I,J).
Systemic TF targeting by antibody does not affect
inflammation but increases the risk of bleeding during acid-
induced ALI
To elucidate a possible systemic role of TF in the pro-
gression of acid-induced ALI, we administered the TF-
Fig. 4. Myeloid tissue factor (TF) deficiency promotes a proinflammatory phenotype of alveolar and bone marrow-derived macrophages
(BMDMs). (A–D) Alveolar macrophages of TFDmye and TF+/+ mice were isolated and stimulated with lipopolysaccharide (LPS) (10 ng mL1)
or vehicle for the indicated time points. Interleukin (IL)-6 (A) (n = 5) and tumor necrosis factor (TNF)-a (C) (n = 3) mRNA expression in iso-
lated alveolar macrophages, stimulated with LPS or vehicle for 3 h were determined by qPCR. Data are depicted as fold TF+/+ control. (B, D)
IL-6 (B) and TNF-a (D) protein levels in supernatants of alveolar macrophages were measured by ELISA at the indicated time points after LPS
stimulation; n = 3. (E–J) Bone marrow cells of TFDmye and TF+/+ mice were differentiated towards macrophages by granulocyte–macrophage
colony-stimulating factor (GM-CSF) (10 ng mL1) and stimulated with LPS (10 ng mL1) or vehicle at the indicated time points. (E) IL-6
mRNA (ncontrol TF+/+ = 5; all others n = 6) expression 3 h after stimulation was quantified by qPCR, and the data are depicted as fold TF
+/+
control. (F) IL-6 (n6 h = 4; all others n = 6). (G) TNF-a (n = 6) levels in supernatants were determined by ELISA. (H–J) EGR1 (H) (n = 5–6),
IKBa (I) (n = 5–6) and STAT1 (J) (n = 5–6) were measured by qPCR, and are depicted as fold TF+/+ control. For statistical analysis, two-way
ANOVA with Sidak’s multiple comparison was performed; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Littermate-controlled experi-
ments were performed. HPRT, hypoxanthine guanine phosphoribosyl transferase; NS, not significant; PBS, phosphate-buffered saline.
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blocking antibody 1H1 intraperitoneally in C57BL/6J lit-
termates [33]. We observed no adverse events such as
fatal bleeding during the 8-h observation period after
intratracheal acid instillation. When we analyzed ALI-
induced leukocyte influx in BALF, we found no differ-
ences for CD45+ leukocytes, Ly6G+ neutrophils, or F4/
80+ macrophages (Fig. 7A–C). In contrast to what was
seen in cell type-specific TF-deficient mice, systemic
blockade of TF led to a significant increase in erythrocyte
numbers in BALF (Fig. 7D), indicating that TF is
required to maintain bronchoalveolar barrier function.
Accordingly, we did not observe gross changes in IL-6
(Fig. 7E) or KC (Fig. 7F) levels.
Discussion
TF and the extrinsic coagulation cascade are intricately
involved in the disease mechanisms underlying ALI. For
instance, exacerbated fibrin deposition is detrimental to
the function of the alveolar–capillary system by causing
barrier dysfunction and hampering gas exchange [34]. We
found that myeloid TF deficiency exacerbated the pathol-
ogy of acid-induced ALI. Surprisingly, TF deficiency of
lung epithelial cells resulted in an unusually long-lasting
(24 h) disease pathology of acid-induced ALI, accompa-
nied by modest intra-alveolar hemorrhage. This is in line
with previous findings showing that epithelial TF exerts
protective effects, e.g. supporting the alveolar–capillary
barrier, in various infectious and non-infectious ALI
models [18,35,36]. For instance, in an LPS-induced lung
inflammation model, the presence of epithelial cell TF
determines the severity of the lung pathology [18,33].
Whereas, in LPS-induced ALI, myeloid TF is of minor
importance [36], we provide evidence that, in acid-induced
ALI, deficiency of myeloid TF promoted the inflamma-
tory response and thereby significantly exacerbated dis-
ease progression. Increased inflammation may be the
reason for increased TF expression in whole lung tissue,
as observed in TFDmye mice as compared with wild-type
mice during ALI. Previous studies have indicated that the
effect of myeloid TF depends significantly on the disease
model. Whereas, in low-TF mice, bacterial burden and
cytokine release were unaltered as compared with
wild-type mice during tuberculosis [37], myeloid TF defi-
ciency augmented the pulmonary growth of Mycobac-
terium tuberculosis, most likely because of reduced fibrin
generation and shifting macrophage polarization [38].
Such disease model-dependent differences could explain
our observations regarding the role of myeloid TF in
ALI. In contrast to LPS-induced ALI, which induces
apoptosis in epithelial and endothelial cells [39,40], acid-
induced ALI creates a direct cell-damaging disease pat-
tern. Intratracheal instillation of HCl mainly affects
epithelial cells, leading to impaired epithelial cell function
and fluid transport, and indirect damage to the capillaries
[41]. Epithelial cell injury was also exemplified by dam-
age-associated release of IL-33 into the bronchoalveolar
space. IL-33 is abundantly expressed in lung epithelial
cells [42]. However, we did not observe any differences in
IL-33 levels in BALF between TFDmye mice and wild-type
mice, indicating comparable initial insults by acid aspira-
tion in both groups. However, during acid-induced ALI,
TFDmye mice showed increased pulmonary TF expression,
indicating enhanced activation of non-hematopoietic cells,
e.g. type I and type II lung epithelial cells, upon acid
injury. The most apparent differences in inflammation
were significant increases in proinflammatory IL-6 levels
and leukocyte/neutrophil influx. These occurred indepen-
dently of coagulation activation or the presence of TF on
epithelial cells, and was solely dependent on myeloid TF.
Although there was a tendency for there to be increased
cytokine expression in TFDmye mice during LPS-induced
ALI, no significant differences were observed [36].
In line with elevated cytokine levels, we also observed
increased recruitment of leukocytes into the bronchoalve-
olar space of TFDmye mice, comprising inflammatory
macrophages and, particularly, neutrophils; however,
total MPO levels were only slightly increased. These find-
ings indicate that, although coagulation is not affected by
the lack of TF on myeloid cells and, in particular, on
alveolar macrophages, the proinflammatory environment
created by acid-induced ALI further substantiates the
damage. This idea is supported by the significant upregu-
lation of proinflammatory cytokines, e.g. IL-6, by isolated
TF-deficient alveolar macrophages upon LPS stimulation
in vitro.
Fig. 5. Epithelial tissue factor (TF) plays a minor role in acid-induced acute lung injury (ALI). Epithelial TF-deficient and wild-type (WT) mice
were treated with HCl for 8 h. (A) TF mRNA expression of lung tissue was determined by qPCR, and is depicted as fold wild-type control (ncon-
trol TF+/+ = 5; ncontrol TFDmye = 3; nHCl TF+/+ = 9; nHCl TFDmye = 10). (B, C) Activated factor X (FXa) generation (B) (ncontrol TF+/+ = 4; ncon-
trol TFDmye = 2; nHCl TF+/+ = 6; nHCl TFDmye = 4) and thrombin–antithrombin (TAT) complex (C) were measured in bronchoalveolar lavage fluid
(BALF) (ncontrol TF+/+ = 4; ncontrol TFDmye = 1; nHCl TF+/+ = 9; nHCl TFDmye = 7). (D) Protein content in BALF samples
(ncontrol TF+/+ = 4; ncontrol TFDmye = 2; nHCl TF+/+ = 10; nHCl TFDmye = 6). (E) Lung edema was determined by measuring the weight ratio of wet
and dried whole lung tissue (ncontrol TFDmye = 2; all others n = 5) (F–H) IL-6 mRNA expression (F) (ncontrol = 4; nHCl TF+/+ = 5; nHCl TFDmye = 8)
and IL-6 protein levels in (G) total lung tissue (ncontrol TFDmye = 1; all others n = 4) and (H) BALF (ncontrol TF+/+ = 4;
ncontrol TFDmye = 1; nHCl TF+/+ = 6; nHCl TFDmye = 3). (I, J) Flow cytometric analysis of (I) neutrophils (CD45
+ Ly6G+ F4/80) and (J)
erythrocytes (Ter119+) in the BALF of epithelial TF-deficient and WT mice (ncontrol TF+/+ = 4; ncontrol TFDmye = 2; nHCl TF+/+ = 11;
nHCl TFDmye = 8). For statistical analysis, the Mann–Whitney test was performed (A, B); ***P < 0.001. Littermate-controlled experiments were
performed. HPRT, hypoxanthine guanine phosphoribosyl transferase; ND, not detectable. [Color figure can be viewed at wileyonlinelibrary.com]
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However, neutrophils can also upregulate TF expres-
sion during inflammation [5,43]. Infection with influenza
virus A/H1N1 induces TF expression on various cell
types, including neutrophils [44]. Thus, we cannot exclude
the possibility that lack of TF on neutrophils contributes
to the observed phenotype during ALI.
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Fig. 6. Leukocyte extravasation into the lung 24 h after HCl-induced acute lung injury (ALI) in epithelial and myeloid tissue factor (TF)-defi-
cient mice. The presence of (A, D) leukocytes (CD45+), (B, E) macrophages (CD45+ F4/80+), (C, F) neutrophils (CD45+ Ly6G+ F4/80)
and (G, H) erythrocytes (Ter119+) in the bronchoalveolar lavage fluid (BALF) was determined by flow cytometry. (I, J) BALF protein was
measured with a bicinchoninic acid assay. (A–C, G) ncontrol = 2–3; nHCl TF+/+ = 5; nHCl TFDepi = 7–8. (D–F, H) ncontrol = 3–4;
nHCl TF+/+ = 12; nHCl TFDmye = 9. (I) ncontrol TF+/+ = 5; ncontrol TF+/+ = 2; nHCl TF+/+ = 6; nHCl TFDepi = 5. (J) n = 2–3. For statistical
analysis, unpaired Student’s t-tests were performed; *P < 0.05. Littermate-controlled experiments were performed.
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TF upregulation during ALI results not only in a mild
hypercoagulable state but also in an inflammatory state,
as FVIIa, FXa, and activated FII can activate protease-
activated receptors, which induce the expression of vari-
ous cytokines [45]. However, we provide evidence that
myeloid TF itself dampens inflammatory reactions via
downregulation of macrophage IL-6 expression. Our data
indicate that there is TF cell type-specific and disease-spe-
cific regulation of inflammatory responses, suggesting that
TF acts as a double-edged sword in the cross-talk
between inflammation and coagulation.
Taking our findings together, we conclude that myeloid
TF has roles in addition to activating the extrinsic coagu-
lation cascade, as TF clearly shows immunomodulatory
potential. Thus, myeloid TF may potently regulate the
intensity of inflammatory responses to exogenous lung
insults such as that caused by gastric contents.
Addendum
J. B. Kral-Pointner designed and performed experiments,
analyzed the results, and wrote the manuscript. W. C.
Schrottmaier and V. Horvath planned and performed
research, and analyzed the data. H. Datler was involved
in data collection and animal experiments. C. Ay, B.
Niederreiter, and L. Hell were involved in data collec-
tion. N. Mackman provided conditional knockout mice
and supervised the study. B. Jilma and J. A. Schmid were
involved in interpreting and discussing the results. A.
Assinger and S. Knapp participated in study design and
contributed to the discussion and interpretation of the
data. G. Schabbauer designed the study, was involved in
result interpretation and discussion of the research pro-
gress, and wrote the manuscript. All authors confirm that
they had full access to the data and the manuscript; they
revised its intellectual content and approved the final
version.
Acknowledgements
We thank H. Paar, B. Birnecker, and A. Kn€obl for their
excellent technical assistance. Floxed TF mice crossbred
with LysMcre and SPC cre mice were a kind gift from N.
Mackman. We wish to thank C. T. Esmon for kindly
providing the fibrin b-monomer-specific antibody 59D8,
C. Binder and M. Schwameis for fruitful discussions, and
J. S. Brunner, L. Hanzl, and T. Afonyushkin for excellent
technical advice. The study was supported by the Aus-
trian Science Fund FWF with the projects FWF-SFB 54
and FWF-P24978.
Disclosure of Conflict of Interests
The authors state that they have no conflict of interest.
Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Data S1. Methods.
Fig. S1. Genotyping data of myeloid and airway epithe-
lial TF-deficient mice.
Fig. S2. Macrophage recruitment into the lung 8 h after
acid-induced acute lung injury (ALI).
Fig. S3. Myeloid TF does not influence leukocyte recruit-
ment during sterile peritonitis.
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Fig. 7. Systemic tissue factor (TF) inhibition in acid-induced acute
lung injury (ALI). Wild-type mice were intraperitoneally injected
with anti-TF blocking antibody (1H1) or vehicle prior to HCl treat-
ment, and parameters were analyzed 8 h after HCl treatment. (A–D)
Extravasation of (A) leukocytes (CD45+), (B) neutrophils
(CD45+ Ly6G+ F4/80), (C) macrophages (CD45+ F4/80+) and
(D) erythrocytes (Ter119+) in the bronchoalveolar lavage fluid
(BALF) was determined by flow cytometry. (E, F) Interleukin (IL)-6
(E) and chemokine (C-X-C-motif) ligand-1 (KC) (F) levels in BALF
were determined by ELISA. (A) ncontrol WT = 5; nHCl WT = 12;
nHCl 1H1 = 9. (B) ncontrol WT = 5; nHCl WT = 8; nHCl 1H1 = 8. (C)
ncontrol WT = 7; nHCl WT = 8; nHCl 1H1 = 8. (D) ncontrol WT = 7;
nHCl WT = 10; nHCl 1H1 = 10. (E, F) ncontrol WT = 3; nHCl WT = 6;
nHCl 1H1 = 6. For statistical analysis, unpaired Student’s t-tests were
performed; *P < 0.05. Littermate-controlled experiments were
performed.
© 2017 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals, Inc. on behalf of International Society on Thrombosis and Haemostasis.
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Fig. S4. No significant changes in IL-12 and IL-1b levels
between myeloid TF and wild-type littermates 8 h after
acid-induced ALI.
Fig. S5. Effect of thrombin and FVIIa on the inflamma-
tory response of macrophages.
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